Please assess the completion status of the following clinical trial:

Trial Title: Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Erectile Dysfunction (ED) patient who has newly been prescribed vardenafil (Levitra film-coated tablet) in accordance with the terms of the local marketing authorization.~* Diagnosis of erectile dysfunction at the discretion of the physician, based on the patients ED history.~* No use of any Phosphodiesterase Type 5 (PDE5) inhibitor within 1 month of study entry.~* Documented Metabolic Syndrome (MetS), preferably according to the definition of the International Diabetes Foundation.~Exclusion Criteria:~* Do not follow the contraindications and warnings of the Summary of Product Characteristics.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).